UTILITY of ScvO 2 and LACTATE

Similar documents
Early Goal-Directed Therapy

Sepsis Management Update 2014

Evidence-Based. Management of Severe Sepsis. What is the BP Target?

Goal-directed vs Flow-guidedresponsive

SEPSIS: Seeing Through the. W. Graham Carlos MD, MSCR, ATSF, FACP

6/5/2014. Sepsis Management and Hemodynamics. 2004: International group of experts,

PERANAN LAKTAT PADA PASIEN KRITIS DI ICU. Prof. Dr. dr. Made Wiryana, SpAn.KIC.KAO

Early-goal-directed therapy and protocolised treatment in septic shock

EARLY GOAL DIRECTED THERAPY : seminaires iris. Etat des lieux en Daniel De Backer

Hell or High Lactate. Charles Bruen, MD. resusreview.com/regionsmar17

Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE

Vasopressors for shock

The Hemodynamic Puzzle

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

Dr. F Javier Belda Dept. Anesthesiology and Critical Care Hospital Clinico Universitario Valencia (Spain) Pulsion MAB

( 12 17mLO 2 /dl) 1.39 Hb S v O P v O2

Fluid Resuscitation and Monitoring in Sepsis. Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS

INTENSIVE CARE MEDICINE CPD EVENING. Dr Alastair Morgan Wednesday 13 th September 2017

Didier Payen, MD, Ph D DAR Lariboisière Université Paris 7 Unité INSERM 1160

Full Disclosure. The case for why it matters. Goal-directed Fluid Resuscitation

Surviving Sepsis Campaign Guidelines 2012 & Update for David E. Tannehill, DO Critical Care Medicine Mercy Hospital St.

Sepsis Management: Past, Present, and Future

The Septic Patient. Dr Arunraj Navaratnarajah. Renal SpR Imperial College NHS Healthcare Trust

DESIGNER RESUSCITATION: TITRATING TO TISSUE NEEDS

4/5/2018. Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY. I have no financial disclosures

Methodological co-investigators

EUROANESTHESIA 2008 Copenhagen, Denmark, 31 May - 3 June 2008 CENTRAL VENOUS OXYGEN SATURATION (SCVO 2 ): INTEREST AND LIMITATIONS

FLUID RESUSCITATION AND MONITORING IN SEPSIS PROTOCOLIZED VS USUAL CARE DEEPA BANGALORE GOTUR MD, FCCP ASSISTANT PROFESSOR, WEILL CORNELL MEDICAL

3/14/2017. Pediatric Sepsis: From Goal Directed Therapy to Protocolized Care. Objectives. Developmental Response to Sepsis

towards early goal directed therapy

How can the PiCCO improve protocolized care?

What is. InSpectra StO 2?

Endpoints of Resuscitation for Circulatory Shock: When Enough is Enough?

Shock - from Diagnostic to Therapeutic Implications

Clinical relevance of perioperative ScvO 2 monitoring

Diagnosis and Management of Sepsis and Septic Shock. Martin D. Black MD Concord Pulmonary Medicine Concord, New Hampshire

Cardiovascular Management of Septic Shock

Frank Sebat, MD - June 29, 2006

Sepsis. From EMS to ER to ICU. What we need to be doing

Red Cell Transfusion triggers: A moving target When, who, and how much?

Acute Liver Failure: Supporting Other Organs

Goal-directed resuscitation in sepsis; a case-based approach

Early goal-directed therapy Where to from here? Rinaldo Bellomo ANZIC Research Centre Melbourne, Australia

Early Goal Directed Therapy in 2015: What Did the Big Trials Teach us?

DO 2 /VO 2 relationships

Objectives. Management of Septic Shock. Definitions Progression of sepsis. Epidemiology of severe sepsis. Major goals of therapy

Obligatory joke. The case for why it matters. Sepsis: More is more. Goal-Directed Fluid Resuscitation 6/1/2013

Update in Critical Care Medicine

Fluid responsiveness and extravascular lung water

Sepsis Update: Focus on Early Recognition and Intervention. Disclosures

DO 2 > VO 2. The amount of oxygen delivered is a product of cardiac output (L/min) and the amount of oxygen in the arterial blood (ml/dl).

Sepsis: Identification and Management in an Acute Care Setting

Role of PoCT in Goal-Directed Therapy in Critical Care Settings

Nothing to disclose 9/25/2017

9/25/2017. Nothing to disclose

Staging Sepsis for the Emergency Department: Physician

Sepsis is an important issue. Clinician s decision-making capability. Guideline recommendations

Updates in Sepsis 2017

FUNDAMENTALS OF HEMODYNAMICS, VASOACTIVE DRUGS AND IABP IN THE FAILING HEART

IV fluid administration in sepsis. Dr David Inwald Consultant in PICU St Mary s Hospital, London CATS, London

การอบรมว ทยาศาสตร พ นฐานทางศ ลยศาสตร เร อง นพ.ส ณฐ ต โมราก ล ภาคว ชาว ส ญญ ว ทยา คณะแพทยศาสตร โรงพยาบาลรามาธ บด มหาวทยาลยมหดล

Presented by: Indah Dwi Pratiwi

Use of Blood Lactate Measurements in the Critical Care Setting

The Vigileo monitor by Edwards Lifesciences supports both the FloTrac Sensor for continuous cardiac output and the PreSep oximetry catheter for

What works in sepsis. Topics. EGDT: Severe Sepsis/ Shock. Sepsis

Red blood cell transfusions Risks, benefits, and surprises

Case year old female nursing home resident with a hx CAD, PUD, recent hip fracture Transferred to ED with decreased mental status BP in ED 80/50

UPMC Critical Care

Low Cardiac Output in the Pediatric Patient

Fluid balance and clinically relevant outcomes

Actualités de la prise en charge hémodynamique initiale Daniel De Backer

Managing Patients with Sepsis

BC Sepsis Network Emergency Department Sepsis Guidelines

Sepsis and septic shock Practical hemodynamic consequences. Intensive Care Training Program Radboud University Medical Centre Nijmegen

SHOCK. Emergency pediatric PICU division Pediatric Department Medical Faculty, University of Sumatera Utara H. Adam Malik Hospital

PHYSIOLOGY AND MANAGEMENT OF THE SEPTIC PATIENT

Sepsis: Update on Diagnosis, Evaluation and Management

Are Patients Hypoperfused in the ED? Rapid Perfusion Assessment in the Emergency Department

This PDF is available for free download from a site hosted by Medknow Publications

Jarisch A. Kreislauffragen, Dünser et al. Critical Care 2013, 17:326 Sunday, March 30, 14

Sepsis or Severe Sepsis? Is there a right thing, and how do we do it?

Dilemmas in Septic Shock

IN THE NAME OF GOD SHOCK MANAGMENT OMID MORADI MOGHADDAM,MD,FCCM IUMS ASSISTANT PROFESSOR

MANAGEMENT OF CIRCULATORY FAILURE

Surviving Sepsis. Brian Woodcock MBChB MRCP FRCA FCCM

Fluids in Sepsis Less is more. Dr Anand Senthi Joondalup Health Campus ED MBBS, MAppFin, GradCertPubHlth,

Initial Resuscitation of Sepsis & Septic Shock

Septic Shock. Rontgene M. Solante, MD, FPCP,FPSMID

Heinz-Hermann Weitkemper, EBCP. 4th Joint Scandinavian Conference in Cardiothoracic Surgery 2012 Vilnius / Lithuania

(Peripheral) Temperature and microcirculation

ENDPOINTS OF RESUSCITATION

EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz

The Ever Changing World of Sepsis Management. Laura Evans MD MSc Medical Director of Critical Care Bellevue Hospital

Introduction. Invasive Hemodynamic Monitoring. Determinants of Cardiovascular Function. Cardiovascular System. Hemodynamic Monitoring

Advancements in Sepsis

Advanced Monitoring of Cardiovascular and Respiratory Systems in Infants Kuwait 2018 Dr. Yasser Elsayed, MD, PhD Director of the Targeted Neonatal

Updates in Emergency Department Management of Sepsis

Pyruvate + NADH + H + ==== Lactate + NAD +

Sepsis care and the new core measures

BIOMARKERS IN SEPSIS: DO THEY REALLY GUIDE US? Asist. Prof. M.D. Mehmet Akif KARAMERCAN Gazi University School of Medicine Depertment of Emergency

Transcription:

UTILITY of ScvO 2 and LACTATE Professor Jeffrey Lipman Department of Intensive Care Medicine Royal Brisbane Hospital University of Queensland

THIS TRIP SPONSORED AND PAID FOR BY

STRUCTURE Physiology - Lactate - ScvO 2 How used - ScvO 2 - Lactate ScvO 2 vs Lactate (early goal directed therapy) Conclusions and Take home message

LACTATE Traditionally, the terms lactate and lactic acid are used interchangeably Lactic acid in human subjects exists predominantly in its ionized form even in severely low ph states Measurements are made of blood or plasma lactate, not lactic acid

LACTATE Glucose + 2ADP + 2NAD + 2Pyruvate + 2ATP + 2NADH Pyruvate + NADH + H + Lactate + NAD +

LACTATE The serum arterial lactate concentration reflects the balance between net lactate production and net lactate consumption/ clearance The daily production of lactate is about 1400 mmol, primarily from skeletal muscle (25%), skin (25%), brain (20%), intestine (10%), and red blood cells (20%).

LACTATE In the critically ill, lactate is produced in tissues outside the usual lactate producers, including the lungs, white blood cells, and splanchnic organs. Note: released in supraphysiologic amounts from the sites of infection and inflammation and is thought to be related to the augmented glycolysis in the recruited and activated leukocytes at the sites of infection

LACTATE Lactate is metabolized primarily in the liver (60%), kidneys (30%) and heart (10%). Elevated serum lactate levels are a product of some combination of excess production and reduced clearance.

LACTATE Okorie and Dellinger Crit Care Clinics 2011;27:299-326

Venous Oxygen Saturation

CaO 2 (ml O 2 /dl) = (Hb x 1.38 x SaO 2 ) + (PaO 2 x 0.003) 12

CvO 2 = CaO 2 -VO 2 /Q DO 2 = Cardiac output (Q) x Arterial oxygen content (CaO 2 ) Q = DO 2 /CaO 2 VO 2 = Q x (CaO 2 -CvO 2 ) CvO 2 = CaO 2 -VO 2 /Q 13

Venous Oxygen Saturation CvO 2 = CaO 2 -VO 2 /Q Reflects the extraction of oxygen from the tissue A surrogate marker of adequacy of circulation/perfusion Basis of Rivers work 14

Venous Oxygen Saturation CvO 2 = CaO 2 -VO 2 /Q If low (particularly in yng fit trauma pts) will indicate under-resuscitation 15

Central and Mixed Venous Oxygen Saturations SvO 2 = pulmonary artery catheter ScvO 2 = central venous catheter 16

CHEST 2004;126:1891 6

Resuscitation 2009;80:811 8 Conclusions: Management of ANZ patients presenting to ED with sepsis does not routinely include protocolised, ScvO2-directed resuscitation. Inhospital mortality compares favourably with reported mortality in international sepsis trials.

EARLY GOAL DIRECTED THERAPY As described by Rivers Addresses 3 sequential physiological targets: 1 IV fluids to achieve a CVP (originally 8-12mmHg) 2 Pressors to achieve a MAP at least 65mmHg 3 Dobutamine or red blood cell transfusions to restore tissue oxygen delivery, as assessed by ScvO 2 of at least 70%. CvO 2 = CaO 2 -VO 2 /Q

300 pts Pts randomly assigned Jones et al JAMA 2010;303:739-46 a) ScvO2 group resuscitated to normalize CVP, MAP, and ScvO2 of at least 70% b) lactate clearance group was resuscitated to normalize CVP, MAP, and lactate clearance of at least 10% The study protocol was continued until all goals were achieved or for up to 6 hours. Clinicians who subsequently assumed the care of the patients were blinded to the treatment assignment.

300 pts Jones et al JAMA 2010;303:739-46 Thirty-four patients (23%) in the ScvO2 group died while in the hospital (95% confidence interval [CI], 17%-30%) compared with 25 (17%; 95% CI, 11%-24%) in the lactate clearance group. This observed difference between mortality rates did not reach the predefined 10% threshold.

Jones et al JAMA 2010;303:739-46 Overall, Jones et al observed a mortality of 23% among patients receiving ScvO 2 guided treatment and a mortality of 17% among those receiving lactate-guided treatment.

Lewis RJ. Editorial JAMA 2010;303:777-9 How should physicians proceed in the initial management of the adult patient with severe sepsis or septic shock? There are really 2 questions to be considered: first, should early goaldirected therapy be used whenever possible, and, second, if so, what should the resuscitation targets be? Lewis RJ Editorial JAMA 2010;303:777-9

Lewis RJ. Editorial JAMA 2010;303:777-9 Thus, uncertainty remains about the true benefit of early goal-directed therapy. Without new trials. clinicians should use the original central venous pressure target of between 8 and 12 mm Hg (unventilated) and a mean arterial pressure target of at least 65 mm Hg I AGREE Lewis RJ Editorial JAMA 2010;303:777-9

Hence ProCESS ARISE ProMISe (USA) (ANZICS) (UK)

Same parameters but including ScvO 2 Am J Respir Crit Care Med 2010;182:752 61

Am J Respir Crit Care Med 2010;182:752 61 348 pts: hospital mortality: 43.5% (77/177) vs 33.9% (58/171) in the lactate group (P=0.067)

166 patients Logical/reasonable algorithm

166 patients Logical/reasonable algorithm Lactate clearance >10% over the first 6 h

Arnold et al Shock 2009;32:35-9

LACTATE CLEARANCE Okorie and Dellinger Crit Care Clinics 2011;27:299-326

LACTATE Okorie and Dellinger Crit Care Clinics 2011;27:299-326

LACTATE Okorie and Dellinger Crit Care Clinics 2011;27:299-326

LACTATE Okorie and Dellinger Crit Care Clinics 2011;27:299-326

INTENSIVE CARE MED 2008;34:2226-34 280 patients, 139 received A and 138 N. Median time to resolution of acute circulatory failure was 35.3 hours with A vs 40.0 with N. There was no difference on MAP or development of organ failure. In severe sepsis, the time to resolution of acute circulatory failure was 35.6 hours with A (n=76) and 50.5 hours with N (n=82). A was associated with significant tachycardia, lactic acidosis and hyperglycaemia in the first 4 hours that resolved after 24 hours of infusion.

INTENSIVE CARE MED 2008;34:2226-34 MAP TARGETS

INTENSIVE CARE MED 2008;34:2226-34

CONCLUSION INTENSIVE CARE MED 2008;34:2226-34 Despite the development of transient metabolic effects associated with adrenaline, there was no difference between infusions of adrenaline and noradrenaline for the resolution of acute circulatory failure in ICU patients.

INTENSIVE CARE MED 2008;34:2226-34 NO DIFFERENCE IN OUTCOME

MAY Anaesth Intensive Care 2011;39:449-455 Hypothesis a lactate stress test may reflect underlying metabolic reserve. Ratio of the change in whole blood lactate concentration to the increase in adrenaline dosage LI=(LAC2 LAC1)/(ADR2 ADR1)=ΔLAC/ΔADR

MAY Anaesth Intensive Care 2011;39:449-455

UTILITY of ScvO 2 and LACTATE I hardly use ScvO2 only useful, at best, if low I use lactate EVERYDAY if its normal pt may not be, but if high pt has a problem

UTILITY of ScvO 2 and LACTATE I hardly use ScvO2 only useful, at best, if low I use lactate EVERYDAY if its normal pt may not be, but if high pt has a problem

TAKE HOME MESSAGE ScvO 2 or LACTATE

TAKE HOME MESSAGE LACTATE